Stevens-Johnson syndrome (Q43948): Difference between revisions
From determinar.ia.br - Determine suas informações
Changed an Item |
Changed an Item |
||
| Property / Linked ICD 10 | |||
| Property / Linked ICD 10: L51.1 / rank | |||
Normal rank | |||
Latest revision as of 11:11, 13 August 2026
Stevens-Johnson syndrome is an immune-complex–mediated hypersensitivity disorder involving mucous membranes (conjunctivae, oral mucosa and genital mucosa) with, by definition, skin involvement limited to no more than 9% body surface area. It is related to toxic epidermal necrolysis and shares many of the same triggers, notably drugs, but the inflammation is centred on and close to mucosal surfaces. Although mortality is low, acute morbidity is high and conjunctival involvement has the potential to cause blindness.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | EB13.0 |
||
| English | Stevens-Johnson syndrome |
Stevens-Johnson syndrome is an immune-complex–mediated hypersensitivity disorder involving mucous membranes (conjunctivae, oral mucosa and genital mucosa) with, by definition, skin involvement limited to no more than 9% body surface area. It is related to toxic epidermal necrolysis and shares many of the same triggers, notably drugs, but the inflammation is centred on and close to mucosal surfaces. Although mortality is low, acute morbidity is high and conjunctival involvement has the potential to cause blindness. |
Statements
CID11:EB13.0
0 references
dki-india-EB13.0
0 references
Concluído
0 references
13 August 2026
0 references
